Pearl Boakye

Pearl joined Bayer UK in 1993 as a Clinical Research Scientist, and over the years has held various positions within Monitoring, Study Management, Line Management and Operational Support across a variety of therapeutic areas. She worked for four years as a Global Outsourcing Specialist for the therapeutic areas of Cardiovascular, Haematology & Specialised Therapeutics, and spent a year in Bayer’s US office in New Jersey.

In April 2011, she was appointed Head, CAPA Management within the Business Excellence Function of Bayer HealthCare’s Global Development Quality Department, and was responsible for directing the CAPA strategy for Global Development. This included standard setting and the development of a harmonized CAPA process and CAPA Tool. Pearl established and leads a cross-functional CAPA Council that oversees the tracking, collation, analysis and reporting of CAPAs for Pharma R&D (Bayer HealthCare).